R
RxCap
RxCap is to provide easy-to-integrate care-critical patient data for Healthcare Enterprises
About RxCap
RxCap is a pioneering company in the healthcare technology sector, focusing on improving patient care through advanced data collection and monitoring solutions. The company primarily serves large healthcare enterprises, including hospitals, clinics, and pharmaceutical companies. RxCap operates in the digital health market, which is rapidly growing due to the increasing demand for remote patient monitoring and data-driven healthcare solutions.
The core of RxCap's business model revolves around its innovative hardware and software products. These include Bluetooth and LTE Smart Caps, which are specialized devices that attach to prescription bottles to monitor medication adherence. These Smart Caps collect real-time data on whether patients are taking their medications as prescribed. This data is then integrated with other biometric information, such as blood pressure, heart rate, and oxygen levels, through RxCap's easy-to-use sensors and cloud services.
RxCap also offers a comprehensive web portal that allows healthcare providers to configure clinical trials, health programs, and patient profiles. This portal can seamlessly integrate with mobile applications and other health platforms, providing a customizable solution for healthcare enterprises. The data collected through RxCap's devices and services offer intelligent insights into patient compliance, enabling healthcare teams to identify non-compliance and intervene appropriately.
The company generates revenue through the sale of its Smart Caps and other hardware products, as well as through subscription services for its data and cloud-based solutions. By providing critical patient data and enabling new healthcare ecosystems, RxCap positions itself as a leading data provider in the healthcare industry.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Lynnfield, United States
- Employees
- 15
- Open positions
- None listed
- Dealroom signal
- 74.4/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, Medication Adherence, Medical Data, remote health monitoring
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | May 2024 | $20M | $79M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for RxCap is 1.3K monthly website visits, up 18.2% over the last three months. RxCap's team grew 25% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about RxCap on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See RxCap’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







